Research Article

Management of Rheumatoid Arthritis (Amavata) with Herbo-mineral formulation - A clinical study

Venkateshwarlu. G*, S.K.Giri1, Jonah.S2, O.R.Sharma3, S.K.Sharma3

 

*Corresponding author: Asstt.Director (Ay),

National Ayurveda Dietetics Research Institute, Ashoka pillar, Jayanagar, Bangalore-11

Email: drvenkatg@gmail.com

 

1 Research Officer (Ay.), NADRI, Jayanagar, Bangalore

2 Asstt.Professor, Dept.of Kayachikitsa, SDM College of Ayurveda, Kuthpady, Udupi

3Assistant Directors (Ay.),   Ayurveda Regional Research Institute, Mandi (H.P).

 

Abstract

Rheumatoid Arthritis (R.A) is a chronic, progressive and disabling auto-immune disease that causes chronic inflammation of the joints. It makes life miserable and crippling due to unknown cause, claiming the maximum loss of human working capacity. The polyarticular joint disease has been described in Ayurveda has high resemblance with Rheumatoid arthritis in modern medicine. The disease draws attention for the consideration of research firstly due to the gravity of the problem and secondly due to lack of adverse free modern drugs for the treatment of R.A. Hence the present study has been taken up to see the efficacy of a combination of herbomineral drugs i.e Sunthi, Guggulu and Godanthi bhasma (1:2:1 ratio) on 71 cases of Amavata (R.A). The study observations showed that the overall treatment response among the cases studied, 10 (15%) cases showed good response, 20 (30%) cases showed fair response, 33 (49%) cases showed mild response and 4 (06%) patients did not show any response and rest 4 cases were dropouts. There was a significant improvement in loss of appetite, anorexia, fever in amavata patients after treatment. Statistical analysis of the mean difference before and after treatment in relief on all the above symptoms except in sub cutaneous nodules and erythrocyte sedimentation rate (ESR), were found highly significant (P<0.0001). It was also observed a definite improvement and subjectively maximum patients had a feeling of well-being. No side effects were reported during and after the treatment.

 

Key words: Rheumatoid Arthritis, Amavata, Herbo-mineral drugs, Ayurveda

 

 


Introduction

Rheumatoid arthritis (R.A) is a chronic multisystem disease of unknown aetiology (1).It is a systemic disorder characterized by chronic inflammatory synovitis involving mainly the peripheral joints (2).The disease apparently has no racial or ethnic discrimination. However, females are affected approximately three times more often than men. There is symmetrical synovitis, with arthralgia, stiffness and swelling and if prolonged destruction of peripheral joints (3). About 1% of the world's population is afflicted by rheumatoid arthritis. Onset is most frequent between the ages of 40 and 50, but people of any age can be affected. Although the cause of rheumatoid arthritis is unknown, non-specific autoimmunity plays a pivotal role in both its chronicity and progression (3).

The polyarticular joint disease, Rheumatoid arthritis clinical symptoms has high resemblance with “Amavata described in Ayurveda. The word ‘Ama’ means toxic material generated as a un wholesome product in the body, due to weakening of digestive fire. This ‘Ama’ is then carried by ‘Vayu’ and travels throughout the body and accumulates in the joints, which is the seat of ‘Kapha’. As this process continuous, all the joints are gradually affected, which results in severe pain and swelling in the joints (4).

In conventional medicine, R.A is typically treated with the synthetic drugs may induce remission. The non-steroidal, anti-inflammatory drugs (NSAIDs) still form the mainstay of drug therapy for rheumatic diseases. They do not cure or permanently reverse the inflammatory process, but by reducing pain, swelling, stiffness, and they improve function and give considerable symptomatic relief. On the other hand, all have potentially adverse effects.

However, in Ayurveda the principal treatment of Amavata (R.A) is more or less etiologically oriented. Since the gastro intestinal sluggishness leads to indigestion and malabsorption is attributed to the cause of this disease, the correction of gastro intestinal hypo function is first line of treatment to reduce the further damage to the tissues. The line of treatment is described as langhana, deepana,   ama pachana and Vatanulomana along with the vata shamaka drugs which acts as anti inflammatory and analgesic action (5).

The CCRAS is incessantly engaged in finding out a safe with better efficacious and affordable treatment with suitable herbal and herbomineral drugs for Amavata (R.A).Clinical trials on Sunthi and Guggulu was carried out by the council and the results were found promising (6). Literature review shows that, an ethanolic extract of the rhizomes of Zingiber officinale was investigated for anti-inflammatory, analgesic, antipyretic, activities in mice and rats showed significant effect(7), Zingiber officinale was also evaluated for its anti-inflammatory activity (8). A dose-dependent inhibition of prostaglandin release effect was observed and was also reported that ginger extract inhibits the cyclooxygenase and 5-lipoxygenase enzymatic pathways which leads to the regulation of prostaglandin and leukotriens biosynthesis (9).

Guggulu (Commiphora mukul) has been evaluated for anti arthritic and anti inflammatory actions (10,11). This effect was also been demonstrated and it has significant anti-inflammatory and antiarthritic activity in the animal experiments (12,13).

But to potentiate additional analgesic action of the combination of Sunthi and Guggulu of council’s earlier studies, Godanthi bhasma (CaSO4, 2H2O), the third component of a mineral origin drug was added. Godanthi bhasma possess the pharmacodynamic properties of agnideepana (digestive), jwarahara (antipyretic), pitta shamaka (pacify the pitta dosha),balya (energetic),sulahara (analgesic) and also asthi poshaka (calcium supplementary)(14)  and the study was planned for trial on 71 established cases of Amavata (RA) and the results are reported.

 

Materials and methods:

A total number of 71 established cases of Amavata were selected for this study from the OPD of Regional Research Institute (Ayurveda), Mandi (H.P) during 2001-2004.Clinical, pathological and biochemical investigations carried out as per the proforma and results assessed according to the assessment criteria.

 

·         Inclusion criteria :

1.      Age between 12-60 years of either sex

2.      Chronicity between 6 weeks to 5years

3.      Morning stiffness

4.      Arthritis of 3 or more joints

5.      Arthritis of hand joints

6.      Symmetrical joints swelling

7.      Subcutaneous nodules over bony prominences (Rheumatoid nodules)

8.      Typical X ray changes which must include erosions or bony decalcification localized in or adjacent to involved joint

9.      Positive test for RA factor (latex fixation test)

 

1.      Age below 12 years and more than 60 years

2.      Chronicity less than 6 week and 5 years

3.      Gout

4.      Osteo arthritis

5.      Gonorrhoeal arthritis/syphilitic arthritis

6.      Tubercular arthritis

7.      Arthritis with malignancy

8.      Acute pyogenic arthritis

9.      Psoriatic arthritis

10.  Osteomyelitis

11.  Rheumatic fever

12.  Ankylosing spondylitis

13.  Arthritis with serious complications

14.  Bursitis

15.  Osteoporosis

16.  Diabetes arthritis

 

Preparation of trial drug:

         Rhizomes of Sunthi (Zingiber officinale Roxb.) 500mg, Exudate of Guggulu (Commiphora wighti (Arn.) Bhand.)1000mg and Godanti bhasma (CaSO4, 2H2O) 500mg were mixed in 1:2:1ratio. Guggulu and Godanti were taken in purified form.

Dose schedule: Sunthi-500mg, Gugulu-1000mg, Godanti-500mg three times daily, oral administration with luke warm water for 6 weeks to assess the improvement on every 15 days follows up.

 

Assessment criteria:

 The assessment was done in respect of subjective and objective improvement in every follow up on the basis of scoring in their category as mentioned in Table.1. The overall treatment response was done on the basis of response above 75%, 50% and 25% and less than 25% are good, fair, poor and no response respectively.

 

Level of study was OPD; type - Single blind trial

 

Criteria for establishment of diagnosis of disease

Data were collected to commencing the therapy and also periodically as per the criteria described below.


 

Table1.Clinical symptoms assessment grade with scoring

 

Subjective

Grade with score

Morning stiffness

Severe:6

Moderate:4

Mild:2

Pain on rest

Severe:9

Moderate:6

Mild:3

Objective

Pain on motion

Severe:9

Moderate:6

Mild:3

Swelling

Severe:15

Moderate:10

Mild:5

Tenderness

G4:20

G3:15

G2:10

G1:5

Muscle power

G0:10

G1:8

G2:6

G3:4

G4:2

G5:0

Restricted movements

Fully restricted:6

Partially  restricted:3

No restriction:0

Sub cutaneous nodules

Present:2

Absent:0

Functional status

Grade 4:6

Grade 3:4

Grade 2:2

Grade 1:0

Fever

Present:2

Absent : 0

ESR

(1st hour)

71mm or more: 6

41mm to 70 mm: 4

20mm to 40 mm: 2

0 mm to 20 mm: 0

Digestive impairment

Constipation

Regular:3

Frequently:2

Occasionally:1

Loss of appetite

Appetite lost:2

Poor appetite:1

Normal appetite : 0

Anorexia

No inclination for diet:2

Less inclination for diet:1

No anorexia : 0

Loose motion

Present:2

Absent : 0



 


Observations and Result:

It was observed that females were more affected than males. The incidence ranging from 46-55 years of age were more followed by 36-45 (Table 2, Fig.1).


 


Table 2. Incidence of Age and Sex

 

Age in years

Male

Female

Total

percentage

12-16

0

0

0

00%

17-25

3

0

3

04%

26-35

3

12

15

21%

36-45

9

13

22

31%

46-55

10

15

25

35.5%

56-60

2

4

6

08.5%

 

27

(38% )

44( 62% )

71

100%

 

Table 3. Duration of illness

 

S.No

Duration of illness

No.of Pts

Total

Percentage

Male

Female

1

6wks to < 1 year

13

25

38

53.5%

2

1-2 yrs

9

8

17

24%

3

2-3

5

8

13

18%

4

3-4

0

2

02

2.82%

5

4-5

0

1

01

1.41%

6

Above 5 yrs

0

0

00

00

 

Total

27 (38%)

44(62%)

71

100%

 

It was observed that patients between 6 weeks to below 1 year duration were more affected compared to other categories (Table3, Fig2.)


 

Table 4. Educational status

 

Educational status

No.of patients

Percentage

Illiterate

13

18%

Read &Write

00

00%

Primary school

08

11.3%

Middle school

06

8.45%

High school

26

37%

Higher studies

18

25%

 

71

100%

Number of high school educated persons was more affected than others (Table 4).

 

Table 5.Diet wise distribution

Nature of Diet

No.of patients

Percentage

Vegetarian-

25

35.2%

Non Veg. diet

38

53.5%

Lacto ova

08

11.3%

Total

71

100%

 

The disease was found to be more susceptible in patients having non vegetarian diet along with irregular bowel habits (Table 5&6, Fig3&4).

 

Table 6. Bowel habits

Bowel habits

No.of patients

Percentage

Regular

21

30%

Constipation

50

70%

Total

71

100%

 

 

Table 7. Occupation wise distribution

Occupation

No.of patients

Percentage

Desk work

19

27%

House wife

34

48%

Field work

15

21%

Business

03

04%

Total

71

100%

 

According to occupation house wives were found more affected than other categories (Table 7).

 

Table 8. Distribution of Prakriti

 

Shareera prakriti

No.of patients

Percentage

Vataja

03

04.2%

Pittaja

04

05.6%

Kaphaja

09

13%

Vata pittaja

02

12.67%

Vatakaphaja

42

59.15%

Pittakaphaja

11

15.49%

Total

71

100%

 

As far as body constitution is concerned, vatakaphaja prakriti persons were more susceptible to the disease (Table 8, Fig. 5)

 


 

 

Table 9. Statistical analysis on the effect of treatment on clinical parameters of Amavata patients [N=67]        [D.F=66]

Clinical parameter

Before Treatment

 

After Treatment

 

 

 

t value

 

p value

 

Significance

Mean ± SD

SEM

Mean ± SD

SEM

Morning stiffness

3.73±1.30

0.16

1.16±1.16

0.14

23.13

<0.0001

Highly significant

Pain on rest

4.88±2.14

0.26

1.97±2.12

0.26

26.47

<0.0001

Highly significant

Pain on motion

5.60±2.15

0.26

2.51±2.19

0.27

24.30

<0.0001

Highly significant

Swelling

6.94±3.37

0.41

2.69±3.41

0.42

19.41

<0.0001

Highly significant

Tenderness

10.52±5.09

0.62

5.15±4.44

0.54

24.33

<0.0001

Highly significant

Muscle power

4.96±2.18

0.27

2.66±2.01

0.25

23.61

<0.0001

Highly significant

Restricted movements

3.72±1.29

0.16

1.03±1.44

0.18

23.78

<0.0001

Highly significant

Sub cutaneous nodules

0.87±1.00

0.12

0.69±0.96

0.12

2.55

p=0.013

significant

Functional status

3.76±1.50

0.18

1.73±1.47

0.18

68.00

<0.0001

Highly significant

Fever

0.63±0.93

0.11

0.18±0.58

0.07

4.36

<0.0001

Highly significant

Loss of appetite

1.16±0.37

0.05

0.27±0.45

0.05

20.71

<0.0001

Highly significant

Anorexia

3.72±1.29

0.16

1.03±1.44

0.18

 

<0.0001

Highly significant

S.D-Standard deviation; S.E.M-Standard error of mean; D.F-Degree of freedom


Statistical analysis of the mean difference before and after treatment in relief on all the above symptoms and Erythrocyte sedimentation rate (ESR) were found highly significant (P<0.0001) except in sub cutaneous nodules (Table 9&10).

 


Table 10. Effect on ESR in patients of Amavata (N=67)

 

Clinical parameter

Before Treatment

 

After Treatment

 

 

 

t value

 

p value

 

Significance

Mean ± SD

SEM

Mean ± SD

SEM

E.S.R

4.00±0.92

0.11

2.24±0.82

0.10

15.11

<0.0001

Extremely significant

 

Table 11. Treatment effect on RA factor in patients of Amavata (N=67)

 

Rheumatoid Arthritis factor

 

Before treatment (positive)

After treatment

No.of Pts

percentage

Positive cases (%)

Negative cases (%)

28

41.8%

18        (26.87%)

10    (14.93%)

 


Before treatment RA test was positive in 28 cases, while after the treatment 10 cases became negative and 18 cases remained positive (Table.11).

Table 12. Result of treatment (n=67)  

 

Response

No.of patients

percentage

Good Response

10

15%

Fair Response

20

30%

Poor Response

33

49%

No Response

04

06%

Total

67

100%

Drop outs=04


The overall treatment responses among the cases studied were as follows: 10 (15%) cases showed good response, 20 (30%) cases showed fair response, 33 (49%) cases showed mild response and 4 (06%) patients did not show any response and rest 4 cases were dropouts (Table 12,Fig.6).

 


DISCUSSION

Rheumatoid arthritis is a complex and variable condition from the point of view of severity. It is usually a “painful nuisance” for which treatment needs to be individualized with optimum dosage of safe, effective and affordable herbomineral drugs i.e rhizomes of Sunthi (Zingiber officinale Roxb.), exudates of Guggulu (Commiphora wighti (Arn.) Bhand.) and Godanthi  bhasma (CaSO4, 2H2O) having digestive, analgesic, antipyretic and anti-inflammatory properties. As per the scientific observations of the selected drugs and also on the basis of ayurvedic line of treatment, the study was aimed at effective control of symptoms without any adverse effects.

In the present study, it was noticed that pain, restricted movements, pain of joints were more in the morning, Metacarpo phalengeal (MCP), wrist and knee joints were more affected. Anorexia, loss of appetite, indigestion and irregular bowels were the common complaints.

The main objective of this trial is to evaluate the efficacy of Sunthi, Guggulu and Godanthi (1:2:1) in controlling the clinical symptomatology of Amavata (R.A). The standard criteria have been used for diagnosis and certain functional tests have also been done for objective evidence. Laboratory parameters like ESR and RA factor have been carried out before and after treatment.

The observations were done on the basis of age and sex wise distribution of data which clearly showed that the incidence of RA is more prone in females with the age group of 36-55 years. Most of the amavata patients were having the history of faulty dietary habits with sedentary life style leads to hypofunction of jatharagni and thus help in pathogenesis of Amavata (R.A). It was observed that more number of cases showed irregular bowel habits or constipation, which is a major causative factor of Amavata. In regards to body constitution, vatakaphaja prakriti patients (59.15%) were more affected the disease. Clinical symptoms like morning stiffness, pain and restricted joint movements were seen in all the patients. Digestive impairment with loss of appetite, anorexia, indigestion etc was noted in maximum patients, which appear due to the nature of amadosha of Amavata. There was significant reduction in clinical symptomatology i.e sandhi sula (pain) sandhi sotha(swelling)  and sandhi stabdata (stiffness of joints) due to its digestive,  carminative properties  of trial drugs, result in inhibition of formation of Ama (toxic substance) and also alleviation of vata and kapha dosha. In spite of this, a definite improvement was also noted and subjectively maximum patients had a feeling of well-being. No side effects were reported during and after the treatment.

 

CONCLUSION

Based on study observations, it may conclude that, the selected trial drugs may have better approach and scope in successful management of Rheumatoid arthritis (Amavata).Clinical symptoms like pain, swelling morning stiffness etc were best-controlled and significant improvement was noticed in digestive impairment. Besides, a definite improvement was noted and subjectively maximum patients had a feeling of well-being. The combination of Sunthi, Guggulu and Godanthi is a balanced and judicious formulation, which synergistically acts in breaking the complex of pathogenesis of the disease Rheumatoid arthritis (Amavata). Besides, the mineral drug Godanthi, a natural purified calcium supplement plays an important role in bone nourishment. No side effects were reported during and after the treatment.

 

Acknowledgement:

The authors are very grateful to the Director General, CCRAS, New Delhi for the encouragement and financial assistance.

 

References:

1.      P.E. Lipsky, Harrison’s Principle of Internal Medicine,ed.by WisonJD,Braunwald E;published by McGeaw-Hill.Inc.,New York,15th ed,chapter-312; 2001, 1928-1936.

2.      Kumar P & Clark M, Clinical Medicine, published by W B Saunders, London, 4th ed., chapter 8 (Rheumatology and Bone diseases); 1999, 447-518.

3.      Chandrasekharan AN, API Textbook of Medicine, ed.Sainani GS published by Association of Physicians of India, Mumbai, 5th ed., Section XVI, chapter 4 (Rheumatology); 1992, 1118-1121.

4.      Murthy KRS,  Madhava Nidanam of Madhavakara, Varanasi Choukambha Orientalia; 1987, Ch.25/1-12.

5.      Ambikadatta sastry, Bhaishajyaratnavali of Govindadasa, 14th edn, Varanasi,Choukambha Sanskrit Sansthan; 2001

6.      Prem Kishore et.al. “Clinical studies on the treatment of Amavata (Rheumatoid arthritis) with sunthi-guggulu”, JRAS.Vol.III; 3-4; 1982: 133-146.

7.      Srivatsava KC and Mustafa T et. al. “Ginger (Zingiber officinale) in rheumatism and musculoskeletal disorders”, Med Hypothesis; 1992, 39(4):342-348.

8.       Mascolo N, Jain R, Jain SC& Capasso F et al., “Ehnopharmacologic investigation of ginger (Zingiber officinale)”, J Ethnopharmacol; 27(12); 1989:129-40

9.      Kuchi F, Iwakami S, Shibuya M et al, “Inhibition of prostaglandin and leukotrine biosynthesis by gingirols and diarylheptanoids”, Chem Pharm.Bull.(Tokyo) 40(2); 1992: 387-391.

10.  Satyavati, GV et al.,  Commiphora mukul Engl.and Tinospora cordifolia Willd. A study of anti inflammatory activity”, Rheumatism, Vol.4; 1969: 141.

11.  Bhattacharya, C et al.,“Guggulu and Rheumatic disease”, Rheumatism,Vol.11; 1975: 16.

12.  Gujral, ML, Saxena PN et al., “An experimental investigation of antiarthritic effect of some indigenous and modern medicine”. Ind.Jour.Med.Res.Vol.44; 1956:657.

13.  Gulati,OP et.al., “Anti inflammatory activity of Guggulu in white  rats”.Rheumatism.Vol.8; 1972: 83.

14.  Sadananda Sharma, Rasatarangini, 11th edn., Varanasi; Chaukhambha Sanskrit Bhavan; 1994.

15.  Nadakarni, K.M, Indian Meteria Medica, Vol.II, 3rd revised edn, Bombay; Popular Prakashan pvt.Ltd; 1982.

 


******